Toxicity profiles in vivo in mice and antitumour activity in tumour-bearing mice of di- and triorganotin compounds

22Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The in vivo toxicity profiles in mice and the antitumour activity in tumour bearing mice were screened for four di-n-butyltin and five triorganotin carboxylates, di-n-butyltin diterebate (5), bis(phenylacetate) (6), bis(deoxycholate) (7), bis(lithocholate) (8), tri-n-butyltin terebate (9), cinnamate (10), and triphenyltin terebate (11). At their maximum tolerated dosis (MTD), no antitumour effect (T/C ~1) was observed for the compounds 5, 7, 9, 10 and 11. The compounds 6 (T/C = 0.51) and 8 (T/C = 0.42) showed clear antitumour activity after single dose administration and might therefore be of interest for further antitumour activity studies.

Cite

CITATION STYLE

APA

Gielen, M., Willem, R., Dalil, H., De Vos, D., Kuiper, C. M., & Peters, G. J. (1998). Toxicity profiles in vivo in mice and antitumour activity in tumour-bearing mice of di- and triorganotin compounds. Metal-Based Drugs, 5(2), 83–90. https://doi.org/10.1155/MBD.1998.83

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free